Pharmaceuticals News and Research

RSS

"Checklists" for evaluating comparative effectiveness research

A new report released today by the National Pharmaceutical Council (NPC) provides guidance in the evaluation of comparative effectiveness research (CER), including easy-to-use "checklists" that help make sure such studies can be used to improve the dialogue between health care providers and patients, as well as better inform health care decision-making.

11 Dec 2009

Prescription Solutions achieves overall generic prescription drug penetration rate of 68.8 percent

Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group company, has achieved an industry-leading overall generic prescription drug penetration rate of 68.8 percent year-to-date for 2009.

11 Dec 2009

Circassia raises GBP15M for development of its novel allergy T-cell vaccines portfolio

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has completed a GBP15 million ($25 million) fundraising. The investment round, which was led by Imperial Innovations and supported by existing shareholders including Invesco Perpetual and Lansdowne Partners, was significantly oversubscribed and is the company's third successful fundraising.

11 Dec 2009

Proscape CLM6 software enables customers to reach full competitive potential

Proscape Technologies, the pioneer and global leading provider of Closed Loop Marketing (CLM) software for Life Sciences companies, today announced that one of the largest pharmaceutical companies in the world has elected to capitalize upon Proscape's market-leading software platform as the key component of their global sales and marketing strategy.

11 Dec 2009

Brandeis researchers reveal the hidden, transient life of protein between active states

Understanding the incredibly speedy atomic mechanisms at work when a protein transitions from one shape to another has been an elusive scientific goal for years, but an essential one for elucidating the full panoply of protein function.

11 Dec 2009

Arena Pharmaceuticals' lorcaserin demonstrates low abuse potential

Arena Pharmaceuticals, Inc. reported that positive data from a clinical trial evaluating the abuse potential of lorcaserin were presented in a poster session at the 48th Annual Meeting of the American College of Neuropsychopharmacology. Data from the trial demonstrate that the risk for abuse associated with lorcaserin is very low.

11 Dec 2009

Study describing solid-state characterization of three forms of finasteride published

Aptuit, Inc. today announced the publication of new research in the December issue of the European Journal of Pharmaceutical Sciences, the official journal of the European Federation for Pharmaceutical Sciences (EUFEPS), which describes the solid-state characterization of three forms of finasteride.

11 Dec 2009

Ajinomoto announces new fermentation initiative to produce amino acids

Ajinomoto announced today a new initiative to develop propriety fermentation technology for producing cystine and cysteine, amino acids important in a wide array of applications, including pharmaceuticals, flavorings, and cosmetics.

11 Dec 2009

Pfizer extends its patient assistance program for unemployed and uninsured Americans

Pfizer today announced it will extend its MAINTAIN™ (Medicines Assistance for Those who Are in Need) patient assistance program for an additional year, through December 31, 2010. In addition to the more than 70 Pfizer primary care medicines currently available through MAINTAIN, Pfizer will extend the benefits of MAINTAIN to many legacy Wyeth medicines.

11 Dec 2009

ThromboGenics initiates Phase II trial of microplasmin for wet AMD

ThromboGenics NV, a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, announces today that it has started a Phase II trial of microplasmin for the treatment of exudative (wet) Age-related Macular Degeneration (AMD).

11 Dec 2009

microRNA-206 plays crucial role in the progression of ALS

miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA-based therapeutics for cardiovascular and muscle disease, today announced the publication of data demonstrating that microRNA-206 (miR-206) plays a crucial role in the progression of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and in neuromuscular synaptic regeneration in mice.

11 Dec 2009

Instem opens new office in Shanghai to support Chinese pharmaceutical and R&D market

Instem, a leading provider of early drug development software solutions, announced today the establishment of an office in Shanghai to provide local customer support, service delivery, client management, development and sales support to the Chinese pharmaceutical and wider life sciences R&D market.

11 Dec 2009

Winners of the 2010 ASBMB-Merck Award

James A. Wells, professor and chairman of the department pharmaceutical chemistry at the University of California, San Francisco, and director of UCSF's small molecule discovery center, has been named the winner of the 2010 American Society for Biochemistry and Molecular Biology-Merck Award for his pioneering studies in the field of protein engineering.

11 Dec 2009

BioWorld highlights the development of 97 drugs and vaccines to treat HIV/AIDS

BioWorld Today recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America (PhRMA) that identifies 97 new drugs and vaccines in development to treat or prevent HIV/AIDS and related conditions.

11 Dec 2009

FDA approves Lannett's Hydromorphone Hydrochloride Tablets

Lannett Company, Inc. today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg and 8 mg, the generic equivalent of Purdue Pharmaceuticals’ (formerly Abbott’s) Dilaudid® Tablets 2 mg, 4 mg and 8 mg.

11 Dec 2009

Cequent Pharmaceuticals' IND application for CEQ508 approved for clinical trial

Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) approved Cequent's first IND (investigational new drug) application yesterday.

10 Dec 2009

AFP examines insecticide resistance's effect on malaria fight in Nigeria

Agence France-Presse examines the increase in insecticide-resistant mosquitoes in Nigeria - "the latest threat to combating malaria" in the country. "Nigeria, Africa's most populous country, contributes more than a quarter of the one million malaria deaths in Africa, according to official statistics," AFP writes.

10 Dec 2009

Drug importation takes center stage on Senate floor

Debate on a proposal that would make it easier to bring prescription drugs into the country from abroad is taking center stage on the Senate floor as part of the health care reform debate.

10 Dec 2009

InNexus Biotechnology, XERIS Pharmaceuticals collaborate in development of novel antibody delivery system

InNexus Biotechnology Inc. and XERIS Pharmaceuticals, Inc. announced today a research collaboration in which the companies will pursue development of a potential subcutaneous delivery of InNexus’ Dynamic Cross Linking (DXL™) antibodies using XERIS’ proprietary formulation-injection technologies.

10 Dec 2009

Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA

Salix Pharmaceuticals, Ltd. today reported that the Company held a pre-NDA meeting on December 8, 2009 with the FDA to discuss the Company’s proposed new drug application (NDA) for rifaximin in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS).

10 Dec 2009

Pharmaceuticals News and Research

"Checklists" for evaluating comparative effectiveness research

Prescription Solutions achieves overall generic prescription drug penetration rate of 68.8 percent

Circassia raises GBP15M for development of its novel allergy T-cell vaccines portfolio

Proscape CLM6 software enables customers to reach full competitive potential

Brandeis researchers reveal the hidden, transient life of protein between active states

Arena Pharmaceuticals' lorcaserin demonstrates low abuse potential

Study describing solid-state characterization of three forms of finasteride published

Ajinomoto announces new fermentation initiative to produce amino acids

Pfizer extends its patient assistance program for unemployed and uninsured Americans

ThromboGenics initiates Phase II trial of microplasmin for wet AMD

microRNA-206 plays crucial role in the progression of ALS

Instem opens new office in Shanghai to support Chinese pharmaceutical and R&D market

Winners of the 2010 ASBMB-Merck Award

BioWorld highlights the development of 97 drugs and vaccines to treat HIV/AIDS

FDA approves Lannett's Hydromorphone Hydrochloride Tablets

Cequent Pharmaceuticals' IND application for CEQ508 approved for clinical trial

AFP examines insecticide resistance's effect on malaria fight in Nigeria

Drug importation takes center stage on Senate floor

InNexus Biotechnology, XERIS Pharmaceuticals collaborate in development of novel antibody delivery system

Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence